Why Treating Lyme Disease Is More Complex Than You Think

Lyme disease treatment has changed dramatically over the years
New infections, co-infections, and persistent symptoms complicated care
Experience taught me that one treatment approach does not fit everyone

When I first began treating Lyme disease, the treatment options were far more limited than they are today. As new research emerged and more patients presented with complicated illness patterns, my approach evolved.

What seemed straightforward early in my career became more complicated as patients presented with neurological symptoms, persistent illness, and co-infections that required broader clinical thinking.

Early Changes in Lyme Disease Treatment

By 1990, I had started prescribing intravenous ceftriaxone (Rocephin), based on emerging reports describing benefits in chronic neurologic Lyme disease. This adjustment was influenced by reports from Dr. Logigian, Dr. Kaplan, and Dr. Steere, who documented treatment approaches for patients with neurologic involvement.

I also began incorporating azithromycin (Zithromax) and clarithromycin (Biaxin) into my practice as additional treatment options as evidence emerged supporting broader antibiotic strategies in selected cases.

When Babesia Changed Everything

My practice changed again when Babesia emerged as an important co-infection.

Dr. Krause and colleagues reported Babesia infections occurring in the same ticks that transmit Lyme disease. This discovery changed how many clinicians approached patients who failed to improve despite standard Lyme treatment.

At the time, treating Babesia was difficult because clindamycin and quinine were often poorly tolerated. Later, alternative regimens such as atovaquone (Mepron) combined with azithromycin offered more tolerable treatment options.

I increasingly prescribed these therapies for patients whose symptoms suggested persistent co-infection rather than isolated Lyme disease.

Persistent Symptoms and Combination Therapy

Over the years, I adapted my practice to include longer treatment durations and combination therapies in selected patients.

Patients with persistent symptoms often presented differently than textbook Lyme disease cases. Some had neurological problems, others had autonomic dysfunction, and many had overlapping co-infections.

I also incorporated treatment strategies for Bartonella, which was initially associated mainly with cat scratch disease but later emerged as a possible tick-borne co-infection in some patients.

New Theories Influencing Lyme Disease Treatment

In addition to antibiotics, I have followed developments involving disulfiram (Antabuse), double-dose dapsone protocols, and other emerging treatment strategies.

While I have not broadly adopted these approaches, I remain open to evidence-based therapies as new data emerge.

The concepts of persisters and biofilms also influenced how clinicians think about treatment failure.

The persister hypothesis suggests that a subset of bacteria may survive despite standard treatment approaches. These theories borrowed from research involving persistent infections such as tuberculosis and have influenced discussions surrounding treatment duration and complexity.

Why Lyme Disease Treatment Requires Individualization

Antibiotics remain central to my treatment approach. However, experience has taught me that patients often require individualized plans that account for symptom severity, neurological involvement, co-infections, and treatment tolerance.

I also collaborate with other healthcare professionals when needed because many patients benefit from multidisciplinary care.

Lyme disease management has become increasingly complex—not because treatment has failed—but because we now recognize more variables affecting recovery.

FAQ

Why can Lyme disease treatment become complicated?

Patients may have neurologic involvement, delayed diagnosis, co-infections, autonomic dysfunction, or persistent symptoms that require individualized treatment plans.

What is Rocephin used for in Lyme disease?

Ceftriaxone (Rocephin) is commonly considered when Lyme disease affects the nervous system, heart, or causes severe neurologic symptoms.

Why is Mepron used in Lyme disease treatment?

Mepron (atovaquone) is often prescribed when clinicians suspect Babesia, a parasite transmitted by ticks that can occur alongside Lyme disease.

Do all Lyme disease patients need combination antibiotics?

No. Treatment decisions vary depending on symptoms, stage of illness, and clinical presentation.

Clinical Perspective

My experience treating Lyme disease since the late 1980s has reinforced that treatment decisions are rarely one-size-fits-all. The evolution of Lyme disease care reflects a growing understanding of neurologic disease, co-infections, and treatment complexity.

Clinical Takeaway

Lyme disease treatment has evolved from simple antibiotic protocols to more individualized approaches that consider neurologic involvement, co-infections, and persistent symptoms. Recognizing complexity early may help guide more effective care.

Cameron D, Gaito A, Harris N, Bach G, Bellovin S, Bock K, et al. Evidence-based guidelines for the management of Lyme disease. Expert Rev Anti Infect Ther. 2004;2(1 Suppl):S1-S13.

Logigian EL, Kaplan RF, Steere AC. Chronic neurologic manifestations of Lyme disease. N Engl J Med. 1990;323:1438-1444.

Krause PJ, Telford SR 3rd, Spielman A, Sikand VK, Ryan R, Christianson D, et al. Concurrent Lyme disease and babesiosis. Evidence for increased severity and duration of illness. JAMA. 1996;275(21):1657-1660.

Hirsch AG, Poulsen MN, Nordberg C, Moon KA, Rebman AW, Aucott JN, et al. Risk Factors and Outcomes of Treatment Delays in Lyme Disease: A Population-Based Retrospective Cohort Study. Front Med (Lausanne). 2020;7:560018.

Feder HM Jr, Johnson BJ, O’Connell S, Shapiro ED, Steere AC, Wormser GP, et al. A critical appraisal of “chronic Lyme disease.” N Engl J Med. 2007;357(14):1422-1430.

---

Dr. Daniel Cameron, MD, MPH
Lyme disease clinician with over 30 years of experience and past president of ILADS.

Symptoms • Testing • Coinfections • Recovery • Pediatric • Prevention